Jointly led by Mark Lutes, George Breen and Amy Dow from Chicago, the group at Epstein Becker & Green, P.C. primarily works out of the Washington DC office, leveraging the group’s prior government regulatory experience. Lutes is known for his regulatory expertise regarding healthcare investments, Breen is a litigator who handles FCA investigations, and Dow is a life sciences specialist. Amy Lerman routinely advises academic medical systems and telehealth providers on the regulatory implications of transactions. Anjali Downs is noted for her extensive expertise in Anti-Kickback and Stark issues, often assisting ambulatory centers, while New York’s Arthur Fried focuses on compliance issues affecting teaching hospitals and non-profit health systems. Lynn Shapiro Snyder has longstanding experience in reimbursement and enforcement matters, and David Matyas assists hospital systems and private equity investors with government investigations.
Testimonials
Collated independently by Legal 500 research team.
‘This firm, especially in the healthcare regulatory space is phenomenal. They are a true balance of legal authority combined with business strategy. That is a rare characteristic from my perspective. Their ability to understand the business needs is also a significant attribute.’
‘David Matyas - the godfather of regulatory. He has a background and experience that I have not seen from a healthcare regulatory attorney. His business acumen is c-suite, and combining that with legal expertise is powerful.’